Evidence Generation Planning

The difference between what a brand team needs and the evidence that is currently available is what we call an evidence gap.

Evaluating evidence gaps (i.e., performing a gap analysis) is central to evidence generation plan development.

We start with what Market Access needs to convince Managed Care to put their product on formulary and increase access. We identify what evidence is available to support Market Access messages.

An evidence generation plan for Market Access for a product has several components:

• Considering what evidence needs to be generated.
• Determining how that evidence links to Market Access messaging.
• Determining the priority of each of those messages.
• Determining the priority of each of the missing pieces of evidence that would support those messages.

Often the evidence generation plan derived from marketing groups requires health economics expertise and translation before implementation.

Incorporating HEOR expertise earlier in the process would obviate the need to rework completed documents and analyses. 

Excellent planning makes timelines shorter and analytics budgets smaller.

An effective evidence generation plan includes key messages, rationale, gap analysis and identification, and prioritization. 

Though most of this information comes from the pharmaceutical manufacturer client, Health Analytics collates and puts it into a format appropriate for HEOR implementation.

The Health Analytics plan streamlines the process by eliminating the need to translate the final plan into HEOR terms.